Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.590
+0.020 (1.27%)
At close: Mar 25, 2026, 4:00 PM EDT
1.580
-0.010 (-0.63%)
After-hours: Mar 25, 2026, 7:32 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $11.44 million as of March 25, 2026. Its market cap has decreased by -55.41% in one year.
Market Cap
11.44M
Enterprise Value
1.07M
1-Year Change
-55.41%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $11.44M, a decrease of -98.19%. That is a compound annual growth rate of -54.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 11.44M | 12.60% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 13.19M |
| Acurx Pharmaceuticals | 12.92M |
| Kairos Pharma | 12.89M |
| Cadrenal Therapeutics | 12.77M |
| Genenta Science | 12.74M |
| BioCardia | 12.74M |
| OSR Holdings | 12.29M |
| Soligenix | 12.20M |